February 25, 2021

Storms Freeze Distribution of Six Million Doses of Vaccine
The massive winter storms that saw temperatures as much as 40 degrees below average across much of the United States last week put many states’ COVID-19 vaccination programs on ice. What will be the impact on distribution going forward? Read on to learn more on how these delays affect vaccination plans in pharmacies across the country.

Advertisement

Didn’t Buy an Ultra-Low Freezer for COVID-19 Vaccine? You May Be in Luck
The special handing required for the Pfizer-BioNTech vaccine has posed one of the biggest challenges to the U.S. vaccination program. A recent submission of data to the U.S. FDA could significantly reduce the barriers to using the vaccine in more locations, providing much greater flexibility in distribution and potentially increasing access and convenience for pharmacies. What changed? Read more.

About Those Variants . . . Authorized COVID-19 Vaccines Still Work
As the number of potentially concerning variants of SARS-CoV-2 continues to grow, the public might wonder whether getting the current vaccines makes sense. As a pharmacist, you can assure patients that research indicates that the authorized mRNA vaccines made by Pfizer-BioNTech and Moderna still neutralize the virus and offer protection. Two recent studies provide more information.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App
Advertisement